Explore What We Learned at the 8th Clinical Quality Oversight Forum 

Veristat’s Senior Director of Corporate Compliance attended the 8th Clinical Quality Oversight Forum, an annual conference which took place 10-13 October 2017 in Philadelphia, PA.   

In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy. 

A Recap of EMSO 2017 |  By Theresa Bruce, Vice President of Clinical Operations at Veristat

Reflecting on the ESMO 2017 Congress that took place in Madrid on 8-12 September, there was a certain frisson of excitement and anticipation around the presentations of the latest science, the occasion to network with colleagues and clinicians, and the opportunity to learn about rapidly developing trends in cancer care and research.

Veristat clinical trial project teams help our clients reach their clinical trial milestones and achieve success every day.  

To Improve Real-Time Visibility of Clinical Trial Documentation and Inspection-Readiness

Veristat has completed the validation and configuration of Master Control’s eTMF system, which is now implemented and available for Veristat managed clinical trials. 

Last week, Veristat attended the Massachusetts Biotechnology Council (MassBio) forum titled “Evolution of an Academic Discovery: First Person Account of the Development of Velcade®”.   

You went into the biotech and pharma industry to be a SAS programmer, biostatistician, CRA, project manager, or medical writer - not to be a sales person. Then, as you grew your career in the industry, you suddenly found yourself interacting with clients on a regular basis and attending bid defenses. Have you ever wondered how sales became such a large part of your role?

On Thursday, March 2, Veristat was buzzing with excitement as it officially opened its new office in Morrisville, NC.

On Saturday, February 4, Team Veristat joined the battle against rare cancers at the 2017 Cycle for Survival event! Team Veristat had 14 riders at the Boston, MA event, including 2 colleagues from our UK office.  Our team surpassed our goal of raising over $25,000 to fund rare cancer research!

One of the many perks at Veristat is that employees are encouraged to take a paid Day of Service every year to spend time volunteering and giving back to their surrounding community.    We believe that part of making a difference in the world means making the time to help others.